PATENT CLAIM ANALYSIS

Application Number: 15745217
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "013300"]

Abstract:
The present invention relates to a novel polypeptide having chemokine activity and, more specifically, to a polypeptide composed of the amino acid sequence represented by SEQ ID NO: 1 and a use thereof. The polypeptide of the present invention is composed of SEQ ID NO: 1 and exhibits chemokine activity through the binding with CCR3, and thus, the polypeptide has a high utilization effect for various purposes, such as immunoregulation, and diagnosis, treatment, and medicine development for CCR3-mediated diseases or disease symptoms.

Claim (Index 20):
A method for a CCR3-mediated disease-specific drug delivery to a subject, the method comprising administering an effective amount of a composition comprising the polypeptide of  claim 1  to the subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.64912
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11216610', '15639434', '10283028', '10260270', '15629700']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7068909162378937
- 35 USC 102 Novelty (BERT): 0.4940260083320502
- Combined Prediction Score: 0.6856044254473094
- Mean Citation Score: 219.21281800000003
- Max Citation Score: 232.83298
- Similarity Product: 186.027006411643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test